Allen & Overy (A&O) has advised MBDA UK Limited on its landmark GBP4 billion Polish air defence deal. MBDA UK Limited (MBDA) has secured a GBP4bn...
You must be a Standard 1 Year member to access this content.
A&O advised Shionogi on its strategic joint venture. Shionogi & Co., Ltd. (Shionogi) has recently entered into a strategic collaboration and formed a joint venture with...
You must be a Standard 1 Year member to access this content.
Allen & Overy has advised Exscientia on its USD674 million AI drug discovery collaboration with Merck KGaA. Collaboration is set to harness Exscientia’s precision design capabilities...
You must be a Standard 1 Year member to access this content.
Allen & Overy has advised Exscientia on the matter. Sanofi and Exscientia announced a ground breaking research collaboration and licence agreement to develop up to 15...
You must be a Standard 1 Year member to access this content.
Allen & Overy has advised Exscientia on the matter. The collaboration will leverage Exscientia’s AI-driven drug discovery platform to accelerate the discovery of multiple small molecule...
You must be a Standard 1 Year member to access this content.
Allen & Overy advised Exponent Private Equity on the deal. Exponent Private Equity agreed to sell BBI Healthcare (BBIH) to Venture Life Group plc (Venture Life)....
You must be a Standard 1 Year member to access this content.
Allen & Overy has advised Exscientia on the deal. The collaboration will use AI to accelerate the discovery of small molecule therapeutic drug candidates in multiple...
You must be a Standard 1 Year member to access this content.
